RECRUITING

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Talk to us

Conditions

Degenerative Osteoarthritis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study is being done to investigate the colonization rate(growth rate) of a particular type of low-virulence (does not typically cause infection) bacterium called Propionibacterium, more specifically P acnes, the same bacterium that is responsible for the majority of acne. Information affecting hip surgery is currently unknown.

Official Title

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Quick Facts

Study Start:2019-02-02
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03849885

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients who are 18 to 79 85 years of age
  2. * CJR primary joint arthroplasty patients who are receiving care at Porter Adventist Hospital
  3. * CJR established primary knee or hip arthroplasty patients with a native hip joint (no replacement on the biopsy side) who volunteers as a research participant.
  4. * CJR patients without a previous arthroplasty procedure who have established care with our practice.
  1. * Previous history of hip infection
  2. * Current antibiotic use or antibiotic use within the past week
  3. * Previous history of Cutibacterium joint infection
  4. * Current immunodeficiency disease or disorder
  5. * Patients with active psoriatic disease or other focal inflammation over the hip
  6. * Previous total hip arthroplasty (bilateral for the case of TKA patients and healthy volunteers, contralateral for THA patients)

Contacts and Locations

Study Contact

Roseann Johnson, BS CCRP
CONTACT
303-260-2940
roseannjohnson@centura.org

Principal Investigator

Jason M Jennings, MD DPT
PRINCIPAL_INVESTIGATOR
Colorado Joint Replacement

Study Locations (Sites)

Colorado Joint Replacement
Denver, Colorado, 80210
United States

Collaborators and Investigators

Sponsor: Colorado Joint Replacement

  • Jason M Jennings, MD DPT, PRINCIPAL_INVESTIGATOR, Colorado Joint Replacement

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-02-02
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2019-02-02
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Degenerative Osteoarthritis